new glp 1 gip Dual GIP/GLP-1 receptor agonists: advances for treating type-2 diabetes GLP-1 + GIP Injections -

9,12 Additionally, GLP-1RAs activate nitric oxide (NO) synthase expressed in Schlemms canal and the trabecular meshwork, increasing NO production to reduce trabecular meshwork contraction, improving aqueous outflow

The percentage of adults with GLP-1 prescriptions increased from 0.87% in 2019 to 4.03% in 2024, representing nearly 600% growth over six years ^18

Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation

Weight loss may be associated with other symptoms, e.g., muscle loss, fatigue, menstrual changes, gallstones, and mood changes

, Atkinson, M